Dr Prasad Eswaran M.B.B.S., D.M.R.T, M.D, D.M. (Rad. Onc)

Specialty

Oncology & Hematology

Hospital Affiliation

Billroth Hospital, Chennai
Billroth Hospital, Chennai, India

Certification

MCI

Current Position

Radiation Oncologist, Dept. of Oncology, Billroth Hospital, Chennai, India

Medical Education

Doctorate in Medicine (Fellowship in Oncology), DM,  Madras Medical College & Govt. General Hospital, Chennai, India.

Doctor of Medicine (Residency in Radiation Oncology) , MD, Christian Medical College, Vellore, Tamilnadu, India, 2004-06.

Diploma in Medical Radiology & Therapy (Residency in Radiation Oncology), D.M.R.T, Madras Medical College & Govt. General Hospital, Chennai, India, 2004-06.

Bachelor of Medicine & Bachelor of Surgery - M.B.B.S, Govt. Stanley Medical College & Hospital, Chennai, India, 1998-2004.

Awards & Honors

 
ONCOLOGY FELLOWSHIP AWARDS IN USA  
 
- Awarded American Brachytherapy Society (ABS) Resident HDR Fellowship for the year  
 
- Underwent clinical and didactic training in HDR brachytherapy in Texas Cancer Clinic, San Antonio, Texas, USA.
 
 
INTERNATIONAL ACADEMIC HONOURS
Awarded International travel grant by International Gynecologic Cancer Society (IGCS) – Training at The Thomas and Dorothy Leavey Radiation Oncology Center, Long Beach Memorial Medical Center, California, USA for advanced training in Radiation Oncology.
Awarded International travel grant by American Brachytherapy Society (ABS) for HDR brachytherapy training in Texas Cancer Clinic, San Antonio, Texas, USA.
 
Awarded International grant for attending 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, Massachusetts, USA.  
 
 
NATIONAL (INDIA) ACADEMIC HONOURS             
 
7/2012 Oral presentation in 8th American Head and Neck Society (AHNS) held at Toronto, Canada
 
3/2012 Oral Presentation – Best Clinical Trial Proposal Award – presented in 26th Conference of Indian Cooperative Oncology Network (ICON),  Bangalore, India
 
9/2009  Oral Presentation – Best Thesis Presentation - Submission of results of Indian Cooperative Oncology Network (ICON) trial in National meet – Awarded first prize, Rupees 50,000 in 21st Conference of ICON, Tata Memorial Hospital, Mumbai, India
 
9/2006  Oral Presentation – Best Project Proposal award in National conference – Awarded grant for conducting a trial – 15th Conference of Indian Cooperative Oncology Network (ICON), Trivandrum, Kerala, India
 
9/2005  Oral Presentation – Best paper presentation – Awarded Dr. Padam Singh Award – Association of Radiation Oncologist of India (AROI) – State Conference, September 2005, Madurai, Tamil Nadu, India
 
4/2000  Awarded Kishore Vyaganik Protshahik Yojna (KVPY) Scholarship, April 2000, Indian Council of Medical Research (ICMR), New Delhi, India

Sub-Specialty Interest

Gynecologic Oncology

Head and neck Oncology

Breast cancers

Neuro oncology

Thoracic Oncology

Molecular Oncology & Translational research

Biography

Dr Prasad Eswaran has had a rewarding career as an Oncologist using clinical skills, radiation and chemotherapy aimed to provide best of remediation measures in varied malignancies with patient care being the foremost goal.

Dr Eswaran has more more than 4 years clinical experience in the field of Radiation Oncology as practicing Oncologist.  He is trained in conventional and conformal radiation therapy – planning and treatment delivery; in planning appropriate chemotherapy as indicated. In the course of practice he has also developed the human aspects of practicing medicine with Ability to counsel the patients/relatives regarding issues related to acceptance, building a positive approach & self-confidence, ethics, palliation and end of life care.
At present Dr Eswaran is working as Radiation Oncologist at Dept. of Oncology, Billroth Hospital, Chennai, India. Previously his work appointments included Apollo Specialty Hospital, Madurai; Govt. General Hospital & Post Graduate Institute, Puducherry.


PUBLICATIONs
 
1. Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix – Clinical Oncology, Volume 21, Issue 6, Pages 488-493 (August 2009). 
 
2. A Study to assess feasibility, toxicity and immediate response. Publication Status: In review - Submitted to “Journal of Cancer Research and Therapeutics”. Status – Accepted for publication – Under issue preparation. 


 
PUBLICATION (as abstracts)
 
1. Journal of Supportive care in Cancer. 2011 Jun.
 
2. Role of Upfront HDR Brachytherapy in Dysphagia Palliation in esophageal Malignancies. Journal of Supportive care in Cancer. 2011 Jun.  
 
3. Hypofractionated Radiotherapy and Chemotherapy in advanced Head and Neck Squamous Cell Carcinoma (HNSCC).  Journal of Supportive Care in Cancer. 2012 Jun.
 
4. Concurrent Chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib – A study to assess feasibility, toxicity and Immediate response. (2012, July 21).  
 
5. Toxicity & Response Assessment with Prolonged Infusion Gemcitabine And Gefitinib With Intensity Modulated Radiation Therapy In Recurrent Head And Neck Squamous Cell Carcinoma - A Pilot Study. International Journal of Radiation Oncology Biology Physics. 2012 Oct.

Map Details

Contact Details

Billroth Hospital, Chennai, India
Email
Password


Email ID
Your password will be sent to this email.        signIn


Consult experienced Family
Physician / GP

Guaranteed Answers within 12 Hours
2 Free Follow-up Questions
Upload Medical Reports

$9 / consult

Consult World-renowned
Specialists in 41 Specialties

Guaranteed Answers within 24 Hours
3 Free follow-up Questions
Upload Medical Reports

$25 / consult

Consult a Panel of 4 Specialist
Doctors

Comprehensive Report in 5 Days
5 Free Follow-up Questions
Upload Medical Reports

$180 / consult